Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

More researchers are exploring the potential of mRNA encapsulation into lipid nanoparticles.

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

What will drug development look like aboard a new commercial space station?

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

What do companies need to consider when developing next-gen medicines for rare diseases?

How can multi-column chromatography support companies as they set their sights on intensified bioprocesses?

The COVID-19 pandemic exposed weaknesses in pharma supply chains. It’s time to address these.

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative